BMPR2 and pulmonary arterial hypertension: Furthermore, 5–25% of patients diagnosed as having idiopathic PAH (IPAH) actually have a detectable germline mutation in BMPR2 as well.6–12 Thus, BMPR2 mutations constitute the largest known risk for developing PAH.